Goodwin Procter LLP advised TA Associates on the deal. TA Associates announced its $130 million strategic investment in Stackline. The company will utilize TA’s capital to continue...
TA Associates’ $130 Million Strategic Investment in Stackline
Valo Health’s $2.8 Billion Merger with Khosla Ventures Acquisition Co.
Goodwin Procter LLP advised Valo Health on the deal, while Latham & Watkins LLP represented Khosla Ventures Acquisition Co. Valo Health announced its definitive merger agreement with...
Social Finance’s Business Combination with Social Capital Hedosophia Holdings Corp. V
Goodwin Procter LLP advised Social Finance on the deal. Social Finance, Inc. (SoFi) announced its business combination with SPAC Social Capital Hedosophia Holdings Corp. V (SCH) (NYSE:...
Klaviyo’s $320 Million Series D Financing
Goodwin Procter LLP advised Klaviyo on the deal. Klaviyo announced its $320 million Series D financing. Klaviyo is a leading customer data and marketing automation platform. By...
Klaviyo’s $320 Million Series D Financing
Goodwin Procter LLP advised Klaviyo on the deal. Klaviyo announced its $320 million Series D financing. Klaviyo is a leading customer data and marketing automation platform. By...
Mirati Therapeutics’ Collaboration and License agreement with Zai Lab Limited
Goodwin Procter LLP advised Mirati Therapeutics, Inc. on the deal. Mirati Therapeutics, Inc. (NASDAQ: MRTX) announced its collaboration and license agreement with Zai Lab Limited (NASDAQ:...
Mirati Therapeutics’ Collaboration and License agreement with Zai Lab Limited
Goodwin Procter LLP advised Mirati Therapeutics, Inc. on the deal. Mirati Therapeutics, Inc. (NASDAQ: MRTX) announced its collaboration and license agreement with Zai Lab Limited (NASDAQ:...
TA Associates’ $12.5 Billion Fundraising
Goodwin Procter LLP advised TA Associates on the deal. TA Associates announced its fundraising for TA XIV with total commitments at the hard cap of $12.5 billion....
Centessa Pharmaceuticals’ $330 Million IPO
Wilson Sonsini Goodrich & Rosati and Goodwin Procter LLP advised Centessa Pharmaceuticals on the deal. Centessa Pharmaceuticals, a clinical-stage company employing its innovative asset-centric business model...
Coinbase Global’s Acquisition of Skew Ltd
Goodwin Procter LLP advised Skew Ltd on the deal. Skew Ltd, a leading institutional data visualization and analytics platform for crypto markets, announced its sale to Coinbase...
FQX AG’s $4.7 Million Seed Funding Round
Goodwin Procter LLP advised FQX AG on the deal. BMH BRÄUTIGAM has advised Earlybird Venture Capital. Zurich-based fintech FQX AG announced a $4.7M seed funding round led...
MorphoSys’ $1.7 Billion Acquisition of Constellation Pharmaceuticals
Wachtell, Lipton, Rosen & Katz and Willkie Farr & Gallagher advised Constellation on the deal. Goodwin Procter, Dechert and Maiwald acted as legal advisors to Royalty...